Aadi Biosciences Inc (AADI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 7,212 | 6,179 | 5,353 | 6,326 | 5,959 |
| Cost of Goods | 804 | 778 | 652 | 927 | 697 |
| Gross Profit | 6,408 | 5,401 | 4,701 | 5,399 | 5,262 |
| Operating Expenses | 20,625 | 21,763 | 24,865 | 24,040 | 23,808 |
| Operating Income | -13,413 | -15,584 | -19,512 | -17,714 | -17,849 |
| Interest Expense | 38 | 58 | 58 | 57 | 58 |
| Other Income | 905 | 1,059 | 1,281 | 1,502 | 1,605 |
| Pre-tax Income | -12,546 | -14,583 | -18,289 | -16,269 | -16,302 |
| Net Income Continuous | -12,546 | -14,583 | -18,289 | -16,269 | -16,302 |
| Net Income | $-12,546 | $-14,583 | $-18,289 | $-16,269 | $-16,302 |
| EPS Basic Total Ops | -0.46 | -0.54 | -0.68 | -0.60 | -0.60 |
| EPS Basic Continuous Ops | -0.46 | -0.54 | -0.68 | -0.60 | -0.61 |
| EPS Diluted Total Ops | -0.46 | -0.54 | -0.68 | -0.60 | -0.60 |
| EPS Diluted Continuous Ops | -0.46 | -0.54 | -0.68 | -0.60 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.46 | -0.54 | -0.68 | -0.60 | -0.60 |
| EBITDA(a) | $-13,675 | $-15,922 | $-19,884 | $-18,156 | $-18,393 |